- Home
- -
- RESEARCH
- -
- Other Vaccines and Biologicals
- -
- RSV Vaccine
RSV Vaccine
Vaccine Trial Centre: RSV Vaccine Project Timeline

2020
2021
- A Phase 1/2 Randomized, Placebo-controlled, Observer-blind Trial to Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand (GPO NDV-HXP-S)
- A Phase 1/2 Study to Evaluated the Safety Reactogenicity and Immunogenicity of Ad26.COV2.S Administered as a Heterologous Booster Vaccination with an Inactivated COVID-19 vaccine (Thai Cov Boost)
2022
A Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of an Ad26.RSV.preF-based Vaccine in the Prevention of Lower Respiratory Tract Disease Caused by RSV in Adults Aged 60 Years and Older